StonvexLoading…
StonvexStonvexStonvexCore line items from BPRN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $31.07M | $130.55M | $98.80M | $66.05M |
Operating Income | $8.05M | $23.68M | $15.77M | $7.48M |
Net Income | $6.23M | $18.61M | $12.53M | $6.07M |
EPS (Diluted) | $0.91 | $2.71 | $1.82 | $0.88 |
Total Assets | $2.25B | $2.29B | $2.23B | $2.24B |
Total Liabilities | $1.98B | $2.01B | $1.96B | $1.98B |
Cash & Equivalents | $119.79M | $135.69M | $72.89M | $21.09M |
Free Cash Flow OCF − CapEx | $4.93M | $20.60M | $8.60M | $3.94M |
Shares Outstanding | 6.80M | 6.77M | 6.77M | 6.81M |